Showing results (11-20 of 26) with videos related to
Sort By:
Pageof 3
Expert Opinion on Therapeutic Targets|May 11, 2019
Visfatin as a therapeutic target for rheumatoid arthritisEloi Franco-Trepat, Ana Alonso-Pérez, María Guillán-Fresco, et al.Journal of Clinical Medicine|April 25, 2020
Caffeine, a Risk Factor for Osteoarthritis and Longitudinal Bone Growth InhibitionMaría Guillán-Fresco, Eloi Franco-Trepat, Ana Alonso-Pérez, et al.International Journal of Molecular Sciences|February 25, 2023
Methylphenidate Promotes Premature Growth Plate Closure: In Vitro EvidenceAndrés Pazos-Pérez, María Piñeiro-Ramil, Eloi Franco-Trepat, et al.Nutrients|July 14, 2023
Formononetin, a Beer Polyphenol with Catabolic Effects on ChondrocytesMaría Guillán-Fresco, Eloi Franco-Trepat, Ana Alonso-Pérez, et al.International Journal of Molecular Sciences|March 28, 2026
Baclofen Promotes Osteochondrogenic Commitment of Mesenchymal Stem Cells: Implications for Heterotopic Ossification RiskMaría Crugeiras-Sampedro, Lorena Zas-Veiga, María Piñeiro-Ramil, et al.Journal of Bone and Joint Infection|September 27, 2019
Commercially available antibiotic-laden PMMA-covered locking nails for the treatment of fracture-related infections - A retrospective case analysis of 10 casesAlberto Jorge-Mora, Samer Amhaz-Escanlar, Sabela Fernandez-Pose, et al.Journal of Shoulder and Elbow Surgery|August 17, 2018
Early outcomes of locked noncemented stems for the management of proximal humeral fractures: a comparative studyAlberto Jorge-Mora, Samer Amhaz-Escanlar, Sabela Fernández-Pose, et al.Frontiers in Bioengineering and Biotechnology|July 7, 2025
Targeting osteoarthritis with small extracellular vesicle therapy: potential and perspectivesAlba González-Rodríguez, F Javier De Toro, Alberto Jorge-Mora, et al.Biomedicines|January 21, 2023
Improved Protocol to Study Osteoblast and Adipocyte Differentiation BalanceAna Alonso-Pérez, María Guillán-Fresco, Eloi Franco-Trepat, et al.Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|September 15, 2022
Repurposing drugs to inhibit innate immune responses associated with TLR4, IL1, and NLRP3 signaling in joint cellsEloi Franco-Trepat, María Guillán-Fresco, Ana Alonso-Pérez, et al.Pageof 3